AIOTF buys CPAT Technologies to expand health traceability in Africa

AIOTF Software acquired Brampton-based CPAT Technologies to combine AI inferencing with GS1-aligned pharmaceutical traceability tools. The companies are launching in Kenya to support the country’s national medication tracking program and fight counterfeit drugs.

Why it matters: - The combined platform is aimed at reducing counterfeit medicines and improving oversight across health supply chains in Africa. - Kenya is the first market, making the deal a test case for broader continental expansion. - The acquisition ties Canadian deep-tech health tools to a national public health and traceability program.

What happened: - AIOTF Software announced the strategic acquisition of CPAT Technologies on August 4, 2026. - CPAT Technologies is a Canadian health-tech company based in Brampton, Ontario. - AIOTF said the acquisition immediately strengthens its push into African markets, starting with Kenya. - The companies plan to support Kenya’s National Pharmaceutical Traceability Programme with the Ministry of Health, the Kenya Medical Supplies Authority and the Pharmacy and Poisons Board.

The details: - AIOTF brings AI inferencing models, data science and digital transformation infrastructure. - CPAT contributes a GS1-compliant track-and-trace suite for pharmaceutical supply chains. - The combined platform is built around four pillars: National Track & Trace System, Facility 360, Practice 360 and Compliance 360. - National Track & Trace System will use unit-level 2D DataMatrix serialization, batch tracking and real-time distribution verification. - Facility 360 covers licensing, supply chain auditability and compliance monitoring for facilities. - Practice 360 centralizes digital credentialing, licensing and professional management for healthcare personnel. - Compliance 360 is designed to enforce GS1 standards across manufacturers, importers, distributors and pharmacies. - Kenya’s rollout is planned in three phases: repository setup, serialization and event-based tracking, and universal traceability with continental expansion. - Phase 1 centers on batch registries plus Facility 360 and Practice 360 deployment. - Phase 2 adds unique 2D DataMatrix serialization for high-risk health products and anomaly detection. - Phase 3 aims for end-to-end visibility from global manufacturing to bedside dispensing. - AIOTF said the acquisition also expands technical training, local capacity building and system integration in Nairobi. - AIOTF said AI inferencing will be used to detect leakages, recall inefficiencies and illicit trade before products reach consumers. - Media contact listed in the release: press@aiotfsoftware.com. - The release also lists AIOTF Software and CPAT Technologies websites. - The release includes an AIOTF LinkedIn page at AIOTF Software on LinkedIn.

Between the lines: - The deal appears designed to package Canadian health-tech expertise into an exportable model for regulated markets. - Kenya’s role suggests AIOTF wants a government-backed reference implementation before broader regional rollout. - The emphasis on GS1 alignment signals a focus on interoperability and standards-based adoption, not just software deployment.

What's next: - AIOTF and CPAT will begin immediate execution of the Kenya traceability program. - The companies expect to expand local training and technical integration work in Nairobi. - If the Kenya rollout succeeds, the companies are positioning the system as a template for other African markets.

The bottom line: - AIOTF is using the CPAT acquisition to move from AI infrastructure into public-health supply chain execution, with Kenya as the first proving ground.